Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2015

Other information pertaining to share-based activity during the three months ended March 31, 2015 and 2014 was as follows (in thousands):



	Three Months Ended March 31,
	2015		2014
Share-based compensation expense	$	3,709	$	2,458
Fair value of shares vested	11,474		9,175
Cash received from option exercises	1,746		488
Tax benefit from option exercises	3,317		1,727

A summary of the status of non-vested restricted shares at March 31, 2015 and changes during the three months ended March 31, 2015 is as follows:



			Weighted
	Number		Average
	of Shares		Grant Price
Non-vested shares at December 31, 2014	668,109		$	33.51
Shares granted	295,527		55.40
Shares vested	(208,701	)	26.62
Shares forfeited	(5,328	)	35.06
Non-vested shares at March 31, 2015	749,607		$	44.05

A summary of stock option activity for the three months ended March 31, 2015 is summarized as follows:



					Weighted
			Weighted		Average
			Average		Remaining
	Number		Exercise		Contractual
	of Shares		Price		Term (in years)
Outstanding at December 31, 2014	158,721		$	22.89	1.7
Options exercised with total intrinsic value of $2.9 million	(76,962	)	22.68
Options terminated	(5,000	)	25.76
Outstanding, Vested and Exercisable at March 31, 2015 with an aggregate intrinsic value of $3.0 million	76,759		$	22.92	0.7

The following is a reconciliation of the numerator and denominators of basic and diluted earnings per share (in thousands, except per share amounts):



	Three Months Ended March 31,
	Earnings		Shares	Per Share
	(Numerator)		(Denominator)	Amount
2015:
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	18,774	47,572	$	0.39
Effect of dilutive securities, options and non-vested shares	—		333
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	18,774	47,905	$	0.39

2014:
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	17,392	31,716	$	0.55
Effect of dilutive securities, options and non-vested shares	—		404
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	17,392	32,120	$	0.54